FDA approves AZOR
[caption id="attachment_51" align="alignright" width="255" caption="Azor"]
[/caption]
[/caption]
The United States food and drug adminstration (FDA) approved Azor as first line treatment for high sever blood pressure. AZOR is formulated by Daiichi Sankyo, Inc. It’s a combination of Amlodipine as Amlodipine besylate and Olmesartan medoxomil. It’s prescribed for patients suffering from high blood pressure that can’t be controlled by the normal single antihypertensive theraby.